Binding Site Information of Target
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T30420 | Target Info | |||
Target Name | SET domain containing 8 (KMT5A) | ||||
Synonyms | SETD8; SET8; SET07; SET domain-containing protein 8; PRSET7; PR/SET07; PR/SET domain-containing protein 07; PR-Set7; N-lysine methyltransferase KMT5A; Lysine-specific methylase 5A; Lysine N-methyltransferase 5A; Histone-lysine N-methyltransferase KMT5A; H4-K20-HMTase KMT5A | ||||
Target Type | Preclinical Target | ||||
Gene Name | KMT5A | ||||
Biochemical Class | Methyltransferase | ||||
UniProt ID |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
Ligand Name: Ademetionine | Ligand Info | |||||
Structure Description | Crystal structure of hSETD8 in complex with histone H4K20 norleucine mutant peptide and S-Adenosylmethionine | PDB:5TEG | ||||
Method | X-ray diffraction | Resolution | 1.30 Å | Mutation | Yes | [1] |
PDB Sequence |
KSKAELQSEE
202 RKRIDELIES212 GKEEGMKIDL222 IDGKGRGVIA232 TKQFSRGDFV242 VEYHGDLIEI 252 TDAKKREALY262 AQDPSTGCYM272 YYFQYLSKTY282 CVDATRETNR292 LGRLINHSKS 302 GNCQTKLHDI312 DGVPHLILIA322 SRDIAAGEEL332 LYDYGDRSKA342 SIEAHPWLKH 352
|
|||||
|
||||||
Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
Ligand Name: Norleucine | Ligand Info | |||||
Structure Description | Crystal structure of hSETD8 in complex with histone H4K20 norleucine mutant peptide and S-Adenosylmethionine | PDB:5TEG | ||||
Method | X-ray diffraction | Resolution | 1.30 Å | Mutation | Yes | [1] |
PDB Sequence |
KSKAELQSEE
202 RKRIDELIES212 GKEEGMKIDL222 IDGKGRGVIA232 TKQFSRGDFV242 VEYHGDLIEI 252 TDAKKREALY262 AQDPSTGCYM272 YYFQYLSKTY282 CVDATRETNR292 LGRLINHSKS 302 GNCQTKLHDI312 DGVPHLILIA322 SRDIAAGEEL332 LYDYGDRSKA342 SIEAHPWLKH 352
|
|||||
|
||||||
Ligand Name: S-Ethyl-L-cysteine | Ligand Info | |||||
Structure Description | Cryo-EM structure of the histone methyltransferase SET8 bound to H4K20Ecx-nucleosome | PDB:7XPX | ||||
Method | Electron microscopy | Resolution | 3.20 Å | Mutation | Yes | [2] |
PDB Sequence |
PVRRSSRKSK
195 AELQSEERKR205 IDELIESGKE215 EGMKIDLIDG225 KGRGVIATKQ235 FSRGDFVVEY 245 HGDLIEITDA255 KKREALYAQD265 PSTGCYMYYF275 QYLSKTYCVD285 ATRETNRLGR 295 LINHSKCGNC305 QTKLHDIDGV315 PHLILIASRD325 IAAGEELLYD335 YGDRSKASIE 345 AHPWLKH
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .ECX or .ECX2 or .ECX3 or :3ECX;style chemicals stick;color identity;select .K:245 or .K:270 or .K:271 or .K:272 or .K:273 or .K:274 or .K:334 or .K:336 or .K:337 or .K:338; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: N-[3-[[7-(2-aminoethoxy)-6-methoxy-2-pyrrolidin-1-ylquinazolin-4-yl]amino]propyl]prop-2-enamide | Ligand Info | |||||
Structure Description | Structure of human SETD8 in complex with covalent inhibitor MS4138 | PDB:6BOZ | ||||
Method | X-ray diffraction | Resolution | 2.40 Å | Mutation | Yes | [3] |
PDB Sequence |
RIDELIESGK
255 EEGMKIDLID265 GKGRGVIATK275 QFSRGDFVVE285 YHGDLIEITD295 AKKREALYAQ 305 DPSTGCYMYY315 FQYLSKTYCV325 DATRETNRLG335 RLINHSKSGN345 CQTKLHDIDG 355 VPHLILIASR365 DIAAGEELLY375 DYGDRSKAS
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .E1J or .E1J2 or .E1J3 or :3E1J;style chemicals stick;color identity;select .A:286 or .A:309 or .A:310 or .A:311 or .A:312 or .A:313 or .A:314 or .A:335 or .A:336 or .A:337 or .A:338 or .A:339 or .A:348 or .A:359 or .A:361 or .A:375 or .A:377; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: 2-(4-Methylpiperazin-1-yl)-3-phenylsulfanylnaphthalene-1,4-dione | Ligand Info | |||||
Structure Description | SETD8 in complex with a covalent inhibitor | PDB:5W1Y | ||||
Method | X-ray diffraction | Resolution | 1.70 Å | Mutation | Yes | [4] |
PDB Sequence |
SRKSKAELQS
241 EERKRIDELI251 ESGKEEGMKI261 DLIDGKGRGV271 IATKQFSRGD281 FVVEYHGDLI 291 EITDAKKREA301 LYAQDPSTGC311 YMYYFQYLSK321 TYCVDATRET331 NRLGRLINHS 341 KSGNCQTKLH351 DIDGVPHLIL361 IASRDIAAGE371 ELLYDYGDRS381 KASIEAHPWL 391 KH
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .9SV or .9SV2 or .9SV3 or :39SV;style chemicals stick;color identity;select .A:300 or .A:303 or .A:304 or .A:306 or .A:307 or .A:309 or .A:310 or .A:311 or .A:384 or .A:388 or .A:391; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: N-[3-[(6,7-dimethoxy-2-pyrrolidin-1-ylquinazolin-4-yl)amino]propyl]propanamide | Ligand Info | |||||
Structure Description | Complex of SETD8 with MS453 | PDB:5TH7 | ||||
Method | X-ray diffraction | Resolution | 1.95 Å | Mutation | Yes | [5] |
PDB Sequence |
KAELQSEERK
245 RIDELIESGK255 EEGMKIDLID265 GKGRGVIATK275 QFSRGDFVVE285 YHGDLIEITD 295 AKKREALYAQ305 DPSTGCYMYY315 FQYLSKTYCV325 DATRETNRLG335 RLINHSKSGN 345 CQTKLHDIDG355 VPHLILIASR365 DIAAGEELLY375 DYG
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .7BY or .7BY2 or .7BY3 or :37BY;style chemicals stick;color identity;select .A:286 or .A:309 or .A:310 or .A:311 or .A:312 or .A:313 or .A:314 or .A:335 or .A:336 or .A:337 or .A:338 or .A:339 or .A:348 or .A:359 or .A:361 or .A:375 or .A:377; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: 7-(2-Aminoethoxy)-6-Methoxy-2-(Pyrrolidin-1-Yl)-N-[5-(Pyrrolidin-1-Yl)pentyl]quinazolin-4-Amine | Ligand Info | |||||
Structure Description | human SETD8 in complex with MS2177 | PDB:5T5G | ||||
Method | X-ray diffraction | Resolution | 2.10 Å | Mutation | Yes | [5] |
PDB Sequence |
SKAELQSEER
244 KRIDELIESG254 KEEGMKIDLI264 DGKGRGVIAT274 KQFSRGDFVV284 EYHGDLIEIT 294 DAKKREALYA304 QDPSTGCYMY314 YFQYLSKTYC324 VDATRETNRL334 GRLINHSKSG 344 NCQTKLHDID354 GVPHLILIAS364 RDIAAGEELL374 YDY
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .75P or .75P2 or .75P3 or :375P;style chemicals stick;color identity;select .A:269 or .A:286 or .A:310 or .A:311 or .A:312 or .A:313 or .A:314 or .A:335 or .A:336 or .A:337 or .A:338 or .A:339 or .A:348 or .A:359 or .A:361 or .A:375 or .A:377; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Turning a Substrate Peptide into a Potent Inhibitor for the Histone Methyltransferase SETD8. ACS Med Chem Lett. 2016 Oct 11;7(12):1102-1106. | ||||
REF 2 | Structural basis of nucleosomal H4K20 methylation by methyltransferase SET8. FASEB J. 2022 Jun;36(6):e22338. | ||||
REF 3 | The dynamic conformational landscape of the protein methyltransferase SETD8. Elife. 2019 May 13;8:e45403. | ||||
REF 4 | SETD8 in complex with a covalent inhibitor | ||||
REF 5 | Structure-Based Design of a Covalent Inhibitor of the SET Domain-Containing Protein 8 (SETD8) Lysine Methyltransferase. J Med Chem. 2016 Nov 10;59(21):9881-9889. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.